Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMNM | AZN | AMGN | GILD | VRTX |
| Company | Immunome Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 21.23 | 192.64 | 370.68 | 146.85 | 481.79 |
| High | 21.40 | 193.65 | 372.98 | 148.22 | 486.66 |
| Low | 19.81 | 189.43 | 365.93 | 144.20 | 469.08 |
| Latest | 20.36 | 189.90 | 366.21 | 144.99 | 469.34 |
| Change | -0.63 | -2.60 | -1.58 | -0.22 | -8.79 |
| % Change | -3.00% | -1.35% | -0.43% | -0.15% | -1.84% |
| Volume | 983,500 | 1,429,000 | 1,500,300 | 4,375,700 | 1,097,500 |
| 20-Day Average Volume | 1,030,380 | 2,012,695 | 2,516,140 | 6,598,125 | 1,481,940 |
| Previous Close | 20.99 | 192.50 | 367.79 | 145.21 | 478.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 21.72 | 201.54 | 376.49 | 148.47 | 478.47 |
| 20-Day Raw Stochastic | 15.62% | 2.35% | 16.11% | 15.66% | 32.61% |
| 20-Day Relative Strength | 42.45 | 43.81 | 50.80 | 52.04 | 49.33 |
| Weighted Alpha | +126.88 | +26.42 | +23.90 | +36.31 | -0.26 |
| Today's Opinion | 24% Buy | 56% Buy | 88% Buy | 88% Buy | 72% Buy |
| Previous Opinion | 40% Buy | 56% Buy | 88% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | 80% Buy | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.23% since 03/06/26 | -2.22% since 03/06/26 | -0.90% since 03/06/26 | +0.74% since 03/06/26 | +2.77% since 03/06/26 |
| Low | 19.81 on 03/13/26 | 189.35 on 03/09/26 | 365.93 on 03/13/26 | 143.49 on 03/09/26 | 450.78 on 03/09/26 |
| High | 22.16 on 03/10/26 | 198.09 on 03/10/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 507.92 on 03/10/26 |
| 1-Month | |||||
| %Chg | -8.12% since 02/13/26 | -7.61% since 02/13/26 | -0.81% since 02/13/26 | -6.45% since 02/13/26 | -4.50% since 02/13/26 |
| Low | 19.81 on 03/13/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 23.10 on 02/18/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 507.92 on 03/10/26 |
| 3-Month | |||||
| %Chg | +4.04% since 12/12/25 | +5.70% since 12/12/25 | +15.25% since 12/12/25 | +20.42% since 12/12/25 | +3.83% since 12/12/25 |
| Low | 19.15 on 01/06/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 27.65 on 02/04/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| 6-Month | |||||
| %Chg | +121.06% since 09/12/25 | +19.34% since 09/12/25 | +32.50% since 09/12/25 | +26.57% since 09/12/25 | +18.96% since 09/12/25 |
| Low | 8.93 on 09/17/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 27.65 on 02/04/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,374,662 | 298,549,792 | 198,263,824 | 180,266,752 | 121,461,280 |
| Shares Outstanding, K | 113,133 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 6,940,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -212,390,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | -57,460,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 2.12 | 0.32 | 0.45 | 0.37 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.65 on 11/06/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 05/11/26 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.10 | 17.28 | 17.91 | 29.99 |